ABSTRACT We have demonstrated that inoculation of female Coturnix with an inhibin-based immunogen (MBP-cINA 521 ) accelerated puberty and enhanced henday egg production (HDEP). Herein, MBP-cINA 521 , a fusion protein, which consists of the bacterial maltose binding protein (MBP) and a fragment of the ∝-subunit of chicken inhibin (cINA 521 ), was tested for its ability to enhance production performance in broiler breeders. Pullets (Arbor Acres Classic Females; n = 60 birds/treatment group) were given (subcutaneously) 0, 1, 3, or 5 mg of MBP-cINA 521 in Freund's complete adjuvant at 20 wk and 4 d of age. Booster immunizations (one-half of the primary dosages) were given at 23 wk of age. The vehicle for controls (CON; no booster) and MBP-cINA 521 -boosted birds was Freund's incomplete adjuvant. Blood samples were obtained at the end of the trial to assess immunological response to the antigen with a titer ELISA. The onset of puberty was assessed by calculation of the average ages at first lay (FIRST) and at 50% egg production (FIFTY). Cumulative percentage HDEP was determined weekly throughout the laying period (40 wk). Egg weight (EWT) and specific gravity (SG) assessments were made periodically during the trial. Body weight gain (BWG) and mor-
INTRODUCTION
The chemistry, production, assay, and biological actions of mammalian inhibin have been reviewed extensively (see Rivier et al., 1987; de Jong, 1988; Ying, 1988; Risbridger et al., 1990; Woodruff and Mather, 1995; Halverson and DeCherney, 1996; Mather et al., 1997) . Information contained in this paper is the subject of one or more of the following US Patents: 5, 725, 858, 5, 747, 659, and 5, 786, 179. 2 Approved for publication by the Director of the Louisiana Agricultural Experiment Station as manuscript Number 01-46-0194. 3 To whom correspondence should be addressed: dsatterlee@ agctr.lsu.edu. 519 tality (MORT) data were also collected. Significant injection treatment differences (P < 0.01) in inhibin antibody titers were detected according to the following order: low dose = intermediate dose > high dose > CON. A dose of MBP-cINA 521 capable of accelerating puberty and increasing overall egg lay was identified. FIRST and FIFTY responses were decreased (P < 0.05) in birds given the intermediate dose (3.0 mg) of MBP-cINA 521 when compared to the CON. FIFTY responses were also lower (P < 0.05) than CON responses in those birds given the highest dose (5.0 mg) of the inhibin antigen. Cumulative HDEP was also higher (P < 0.05), beginning at 3 wk of lay and weekly thereafter (P < 0.05, for the remaining 40 wk), in birds given the intermediate immunogen dosage when compared to the CON. By Week 40, an average increase of 9.5% HDEP was realized in birds given 3.0 mg of MBPcINA 521 . MORT rates were similar in the CON and in the two lowest MBP-cINA 521 treatment groups but were higher (P < 0.05) in those birds given 5.0 mg of the antigen. EWT, SG, and BWG measurements were unaffected by treatment with the inhibin vaccine. In agreement with our findings in quail, immunoneutralization of inhibin enhanced production performance in breeder hens.
Inhibin is a dimeric glycoprotein hormone that is primarily produced by the gonads. It is comprised of a specific α-subunit and one of two chemically distinct, but quite similar, β-subunits (β A or β B ). Therefore, depending on the β-subunit involved, native inhibin exists as inhibin-A (α + β A ) or inhibin-B (α + β B ). Most importantly, α-and β-subunits, when joined by disulfide bonds, demonstrate the ability of inhibin to suppress secretion of folliclestimulating hormone (FSH) from the pituitary (Ling et al., 1986; see below) .
In mammals, inhibin acts as a negative feedback regulator of pituitary FSH secretion in the basal and stimulated states ). Inhibin appears to also function in an autocrine or paracrine manner (Woodruff et al., 1990; Findlay, 1993) . In avian and mammalian females, FSH plays an essential role in the recruitment and subsequent development of ovarian follicles 1986; McDonald, 1989; Johnson, 1997) , and inhibin, through its influences on FSH, provides a natural inhibition of these activities.
A recent, highly successful strategy to induce hyperovulation in mammals has been the development of methods that involve neutralization of native inhibin activity. A variety of inhibin-based antigens (e.g., recombinant DNA derived inhibin α-subunit, synthetic peptide fragments of inhibin α-subunit, and partially purified inhibin from follicular fluid) have been used as vaccines to immunoneutralize endogenous inhibin in many different mammalian species, including cattle (Sunderland et al., 1991; Glencross et al., 1992; Scanlon et al., 1993) , sheep (Forage et al., 1987; Findlay et al., 1989 , Mizumachi et al., 1990 Wrathall et al., 1990) , pigs (Brown et al., 1990; King et al., 1990) , and rats (Rivier and Vale, 1989) . In general, the active immunization schemes used in these studies enhanced ovarian follicular development or ovulation rate, regardless of the antigen used or the species challenged. Data on how levels of FSH fluctuated during the ovulatory cycle of these cycling animals are conflicting. Nevertheless, most workers believe that accelerated ovulation rates found in mammals vaccinated with antigenic inhibin preparations is the likely consequence of elevated plasma FSH levels (Culler and Negro-Vilar, 1988; Rivier et al., 1988; Vale et al., 1988; Martin et al., 1991) .
As pointed out in two recent reviews by Johnson (1993 Johnson ( , 1997 , much less is known about the chemistry, production, assay, and biological actions of inhibin in the regulation of reproductive function in avian females. Indeed, our general understanding of the endocrine control of follicular recruitment and development within the ovary of the hen is poor. Nevertheless, pituitary gonadotropin involvement has been proven (Bahr and Johnson, 1984; Johnson, 1986) , and a role for inhibin in the control of avian gonadotropin secretion and follicular development is becoming increasingly apparent. Growing follicles on the functionally mature ovary of the domestic hen exist in a distinct size heirarchy. A typical ovary contains four to six large (2 to 4 cm in diameter) yolk-filled follicles (F 1 to F 4 , F 6 ), accompanied by a greater number of smaller (2 to 10 mm) yellow follicles, and numerous very small white follicles (Johnson, 1986) . The largest preovulatory follicle (F 1 ) is destined to ovulate the next day, the second largest (F 2 ) on the following day (approximately 26 h later), and so on. Furthermore, it is the largest, graded follicles (and likely to a much lesser extent, the small yellow follicles) that are the primary source of avian inhibin (Johnson, 1993; Johnson et al., 1993a; Johnson and Brooks, 1996) .
Several studies have described a relationship between follicular growth, inhibin, and FSH activity in the domestic fowl. For example, Vanmontfort et al. (1992) used a heterologous (bovine) RIA to show that levels of plasma immunoreactive inhibin fell coincident with ovarian regression during a forced molt. Johnson et al. (1993a) used a similar assay in demonstrating that stimulation of follicular growth in hens following equine chorionic gonadotropin challenge was associated with increased levels of plasma immunoreactive inhibin. In addition, these workers showed that surgical removal of the largest follicles (F 1 to F 4 ) was associated with greater than 50% reduction of the peripheral inhibin pool coupled with a dramatic increase in plasma FSH (Johnson et al., 1993a) . Wang and Johnson (1993) have also demonstrated that larger follicles of older hens laying at a low ovulation rate produced more mRNA for the inhibin α-subunit than the larger follicles of younger hens laying at a high ovulation rate. Furthermore, levels of plasma immunoreactive inhibin were higher in hens demonstrating poor egg production. Interestingly, the increase in inhibin expression was not accompanied by a measurable decrease in plasma FSH. The authors concluded that the increased inhibin expression in poor layers might have exerted a paracrine effect on the ovary that modulated steroidogenesis, or preovulatory follicle development, or both.
As we have indicated earlier (Moreau et al., 1998) , although inhibin likely exerts parallel physiological roles in the control of follicular recruitment and development in fowl as those documented in mammals, in birds, involvement of inhibin in the control of ovulation rate may (Akashiba et al., 1988; Tsonis et al., 1988; Johnson et al., 1993b) or may not (Johnson et al., 1993a; Wang and Johnson, 1993) be through suppression of pituitary FSH secretion. Finally, Vanmontfort et al. (1995) and Johnson and Brooks (1996) have presented evidence that a negative relationship exists between inhibin and FSH in hens, a relationship that appears to become functional at puberty-when follicular development is greatly accelerated.
It is logical to question whether the development of methods similar to those that have involved the reduction of native inhibin activity in mammalian females (see above) would also be effective for increasing ovulation rate in birds. Unfortunately, unlike in mammals, there have been only a few reports of the effects of inhibin immunoneutralization on avian female reproductive performance. We were first to demonstrate that active immunization of Japanese quail with a fusion protein consisting of a portion of the chicken inhibin α-subunit and maltosebinding protein (MBP-cINA 521 ) markedly accelerated the onset of puberty and increased egg lay in Japanese quail (Moreau et al., 1998) . Since this initial report, our laboratory (Cadd et al., 1999) has also shown that the same antigen is efficacious in increasing egg lay in turkeys as well. Other workers (Ahn et al., 2001 ) have used a different inhibin-based antigen (recombinant turkey α-inhibin conjugated to keyhole limpet hemocyanin) in turkeys to demonstrate that inhibin immunoneutralization increases the numbers of nongraded ovarian yellow follicles and levels of mRNA FSH in pituitary extracts.
Although Lovell et al. (2001) have reported the effects of immunization with a synthetic chicken inhibin α-subunit (26-mer) on ovarian follicle characteristics and beginning egg lay in egg-type fowl, to our knowledge, no one has tested the ability of inhibin immunoneutralization to elevate the production of shelled eggs in meat-type chickens. In immunized birds, Lovell et al. (2001) found a favorable alteration in a size class of follicles that corresponds to ova that have just joined the preovulatory hierarchy. However, their immunized egg-type chickens also had an elevated number of postovulatory follicles that might have been associated with an undesirable higher incidence of double egg lay within a 24-h period. Herein, we have tested the ability of the antigen, MBP-cINA 521 , used in our quail and turkey studies to alter egg lay in the most economically important chicken, the broiler breeder hen.
MATERIALS AND METHODS

Animals and Husbandry
Arbor Acres Classic females (n = 240 birds, 20 wk of age) were obtained from a commercial grower and transported to the Louisiana State University Poultry Farm. Pullets were placed into five pens (48 birds/pen) of an open-sided, fan-ventilated house. At placement, birds were randomly assigned to one of four injection treatment groups (60 birds/group) such that all injection treatments were equally represented in all pens (12 birds/treatment per pen). Birds were individually fitted with wing badges according to a specific color-coded injection treatment regime. Pens contained 18 m 2 of wooden slats and 18 m 2 of litter (pine wood shavings). Each pen was equipped with four batteries of trap-nests (two tiers of five nests per battery, 40 trap-nests/pen). Batteries were placed in the center of the slatted floor space. Nest box batteries were arranged in such a manner that birds could not enter or exit nests from the rear. Within each pen, birds were fed and provided with water (ad libitum) on the slats by four tube-type feeders and four automatic cup drinkers (Plasson). The ED (every day) limited feeding method recommended by Arbor Acres was used from 20 wk of age until the end of the trial (approximately 65 wk of age). From 20 to 26 wk of age, subsamples of birds were weighed to make feed adjustments consistent with the achievement of industryrecommended target body weights. To prevent the potential negative effects that handling would have on egg lay, body weight measurements were discontinued thereafter (except for the body weight measurement made at the end of the experiment to calculate body weight gain; see below). A broiler breeder layer mash (LSU BBL; 16% CP, 2,818 kcal ME/kg) was fed throughout the study.
Pullets were grown in a light-tight house, and, at the time of transport to the university (20 wk of age), they were receiving a daily photoperiod of 11 h. Photoperiods for the birds were as follows: from 20 to 22 wk of age, 14 h of light per day; from 22 to 24 wk of age, 15 h of light per day; and, beginning at 24 wk of age and thereafter, a daily photoperiod of 16 h was provided.
Trap-nesting to identify individual eggs with individual hens and their injection treatment was initiated at 23 wk of age. During the lighted portion of the day, nests were checked a minimum of four times daily and more often during hot weather. On a daily basis, trap-nests were locked in a closed position, and perches were lifted to a nonaccessible position approximately 1 h before lights-off.
Treatment Injections
At 20 wk and 4 d of age, pullets were given 0, 1, 3 or 5 mg of an inhibin-based antigen (MBP-cINA 521 ) in Freund's complete adjuvant. Injection volume was approximately 1.0 mL. To maintain bird identity with dosage within a pen, dosage treatments were administered according to the previously assigned specific (different color) wing badges. In other words, within each pen, each of the four different badge colors that were assigned at 20 wk of age were associated at time of injection with a distinct injection treatment dosage. A single booster (onehalf of the primary dosages) was administered at 23 wk of age. The vehicle for control (CON, 0 mg) and MBPcINA 521 -boosted birds was Freund's incomplete adjuvant. All injections were given subcutaneously at one site at the base of the neck.
Cloning, Expression, and Purification of Recombinant MBP-cINA 521
The production and characterization of the immunogen used in these studies, MBP-cINA 521 , has been described in detail elsewhere (Moreau et al., 1998) . Briefly, a protein fusion was constructed that placed 101 amino acid residues of the mature chicken inhibin α-subunit at the carboxy terminus of the bacterial maltose-binding protein (MBP), separated by a short linker sequence (expression vector pMalC2). 4 The protein was expressed in bacteria and purified using amylose affinity chromatography and characterized by SDS-PAGE.
Variables Measured
Daily egg production records were begun on all hens upon observation of the first trap-nested egg collected from any bird (considered Day 1 of the experiment, flock age of 23 wk and 4 d). Thereafter, data were collected for 40 wk of lay. To assess the onset of puberty, the average ages (d) at first egg lay (FIRST) and at 50% egg production (FIFTY) were calculated. Weekly and cumulative weekly hen-day egg production (HDEP, %) was determined throughout the laying period (40 wk of lay).
Egg quality assessments were made throughout the laying period by collecting daily egg weight (EWT, g) and specific gravity (SG) data on all eggs laid during a 1-wk period at each of the following intervals: 10, 16, 22, 28, 34, and 40 wk of lay. Four days of data were lost at the 34-wk interval; therefore, egg quality assessments at this time interval were represented by only 3 d of lay. Egg SG was calculated with the method of Archimedes' Principle: ratio of dry egg weight to the weight of water that the egg displaces, corrected for the temperature of water according to the temperature corrections of Kell (1975) . To determine BW gain (BWG), all hens were weighed (nearest g) at 25 wk of age for comparison with their weight at the end of the trial (64 wk and 3 d of age). Mortality (MORT) observations were made on a daily basis.
All hens were blood sampled (wing vein) at the end of the experiment to assess the degree of inhibin immunoneutralization in MBP-cINA 521 -treated birds as measured by a titer ELISA (see below). Whole blood was collected into heparinized vacutainers and centrifuged at 886 × g; plasmas were withdrawn for frozen storage (−20 C) until their subsequent assay for inhibin antibody titer response.
Titer ELISA
The titer ELISA was conducted essentially as described previously (Moreau et al., 1998) . Briefly, the assay used a recombinant solid phase antigen (Histag-cINA 521 ) that contained 101 amino acids of the mature chicken α-subunit (identical to the test article). Plasma was diluted 1:500, and optical densities produced by the colorimetric reaction of alkaline phosphatase were compared after background subtraction and normalization of values to a positive control.
Statistical Analyses
The HDEP, SG, and EWT data were subjected to an ANOVA that incorporated a randomized block design with a split-plot (repeated measures) arrangement of treatments. For each of these three variables, pens (blocks) and injection dosages (0, 1, 3, or 5 mg MBP-cINA 521 ) were considered on the main plot. The 40 weekly intervals of HDEP, or 6 selected intervals of egg quality measurements (i.e., SG and EWT measurements at 10, 16, 22, 28, 34 and 40 wk of lay), were considered as repeated measures on their respective split plots. HDEP data were also analyzed on a cumulative weekly basis by use of a randomized block design.
Injection treatment differences in FIRST, FIFTY, BWG, MORT, and inhibin antibody titer data were also detected using randomized block design ANOVA (with pens considered as blocks). Where appropriate, for all production performance variables and for the inhibin antibody titer data, post-ANOVA testing to partition differences in injection treatment means was conducted using Duncan's new multiple-range test.
RESULTS
Comparison of Actual Feed Consumption and Body Weights with Target Feed and Body Weights
Figure 1 compares target feed and body weight recommendations published by the primary breeder (Arbor Acres) with weekly feed consumption and realized body weights of the experimental flock from 20 to 26 wk of age. The pullets were approximately 10% below their recommended target body weight upon their receipt at 20 wk of age. As a result, we fed slightly more than the recommended daily volume of feed (particularly during Week 22) to assist the birds in reaching their recommended target body weights. By 23 wk of age, actual and recommended (target) body weights were nearly identical and body weight remained slightly less but similar to target recommendations thereafter (from 24 to 26 wk of age).
Immune Responses After Active
Immunization Against MBP-cINA 521 ELISA analyses of plasma samples collected at the end of the trial (40 wk of lay) demonstrated the presence of antibodies directed against the recombinant inhibin fragment Histag-cINA 521 in MBP-cINA 521 -challenged but not CON-treated birds (Figure 2 ). Significant injection treatment differences (P < 0.01) in inhibin antibody titers were detected according to the following order: low dose = intermediate dose > high dose > CON.
Production Performance Following Immunoneutralization of MBP-cINA 521
Hens of each injection treatment group exhibited similar BWG at the end of the laying cycle (Table 1) . Likewise, egg quality (EWT and SG) measurements made at each of the six selected intervals during egg lay were unaffected by treatment with MBP-cINA 521 (Table 1) . Among these variables, the only statistically relevant finding was the occurrence of transient differences in SG noted at 28 wk of lay. Although mean SG of eggs collected from the CON birds at this time were not different from SG means found in any of the three MBP-cINA 521 -treated groups, hens receiving the highest MBP-cINA 521 dosage had a greater (P < 0.05) mean SG than that detected in either of the lower MBP-cINA 521 treatment groups. Although measurements of the incidences of misshapen, checked, membrane, and double-yolk eggs were not made, our subjective impression was that such variables were not affected by treatment with MBP-cINA 521 . Mean ± SEM MORT rates were similar between the CON (16.7 ± 4.9%) and two lowest dose MBP-cINA 521 treatment groups (15.0 ± 4.6% and 13.3 ± 4.4%, respectively), but MORT was elevated (P < 0.05) in hens given the highest immunogen dose (31.7 ± 6.1%).
Puberty was markedly accelerated in birds actively immunized against inhibin (Figure 3) . When compared to the mean CON response (FIRST = 211.8 d), egg lay was on average initiated nearly 2 wk earlier (P < 0.05) in hens that received 3.0 mg of MBP-cINA 521 (FIRST = 199.2 d). Hens given 1.0 or 5.0 mg of MBP-cINA 521 had mean FIRST responses (204.5 and 202.7 d, respectively) that were intermediate between and not different from those found in the CON and 3.0 mg MBP-cINA 521 groups. Mean FIFTY responses showed even more dramatic immunization effects (Figure 3) . Hens given either of the highest immunogen doses (3.0 or 5.0 mg MBP-cINA 521 ) reached 50% egg production sooner (at 243.9 and 250.7 d, respectively; P < 0.05) than the CON (284.8 d), an average of more than 5 wk. Although birds receiving the low (1 mg) dose of MBP-cINA 521 had a mean FIFTY response (264.8 d) that was 20 d less than that found in the CON, this intermediate response was found to be no different from those responses detected in the CON or the two highest MBPcINA 521 groups. Figure 4 illustrates weekly HDEP rates of the four injection treatment groups. Beginning at 3 wk of lay and weekly thereafter, mean cumulative HDEP was higher (P < 0.05) in hens receiving the intermediate dosage of MBP-cINA 521 when compared to the CON. Similar to FIRST responses, overall HDEP (full 40 wk of lay) was greater (P < 0.05) in the 3.0 mg MBP-cINA 521 group (58.6%) than in the CON (49.2%) with intermediate responses found in the 1.0 (54.0%) and 5.0 (52.2%) mg MBPcINA 521 groups, responses that were no different from the CON or 3.0 mg MBP-cINA 521 groups.
Cumulative number of eggs laid by individuals that were alive at the end of the experiment for the CON (n = 50 birds) and optimal MBP-cINA 521 dose, 3.0 mg (n = 52 birds), are shown in a frequency histogram in Figure  5 . The data showed that although nine CON hens laid less than 100 eggs in 40 wk of lay, only three MBP-cINA 521 -treated hens were in this same category. On the other hand, hens laying at a high rate (>200 eggs during 40 wk of lay) favored the MBP-cINA 521 -injection treatment (11 birds) when compared to the CON (4 birds). Furthermore, cumulative egg production in hens given the inhibin immunogen averaged 20.2 more eggs per hen ( Figure 5 ). 
DISCUSSION
In mammals, inhibin acts as a negative feedback regulator of pituitary FSH secretion and inhibin may function in an autocrine or paracrine manner as well (Woodruff et al., 1990; Findlay, 1993) . In birds and mammals, FSH plays an essential role in the recruitment and subsequent development of ovarian follicles 1986; McDonald, 1989; Johnson, 1997) . Thus, inhibin, through its influences on FSH, provides a natural suppressor of these activities.
In mammals, the combination of the α-and β-subunits of inhibin into inhibin-A (α + β A ) or inhibin-B (α + β B ) is considered obligatory for inhibin to exert its effect of suppression of pituitary FSH secretion (Ling et al., 1986) . Inhibin apparently exists in similar subunit combinations in chickens (Johnson, 1997; Davis and Johnson, 1998) . Moreover, a role for inhibin in the control of avian gonadotropin secretion and follicular development is becoming increasingly apparent (see Introduction). It follows then, that molecular forms of biologically active inhibins similar to those found in mammals likely exist in birds. And, if so, then immunoneutralization of the α-subunit of inhibin in birds should, as in mammals (Forage et al., 1987; Findlay et al., 1989; Rivier and Vale, 1989; Brown et al., 1990; King et al., 1990; Mizumachi et al., 1990; Wrathall et al., 1990; Sunderland et al., 1991; Glencross et al., 1992; Scanlon et al., 1993) , favorably alter FSH release from the pituitary or FSH action on the ovary consistent with the promotion of higher egg lay.
We first tested the effect of active immunization against inhibin on avian female reproductive performance in Co- turnix (Moreau et al., 1998) , a widely accepted research pilot animal model for domestic fowl. In this earlier study, Japanese quail were immunized against recombinant chicken α-inhibin fusion protein, MBP-cINA 521 . In two separate trials, challenge with MBP-cINA 521 resulted in a marked reduction of the average ages at first egg lay and 50% egg production as well as increased total HDEP during a 30-wk period of lay. Herein, we confirm the efficacy of the same antigen to increase egg lay in a second and more economically important avian species, broiler breeder chickens.
A dose of MBP-cINA 521 was identified in broiler breeder hens that significantly accelerated puberty as evidenced by a marked reduction in the average ages at first egg lay and 50% egg production. This same dose, when compared to CON responses, elevated overall HDEP, as well as mean cumulative hen-day egg production rate beginning at 3 wk of lay and weekly thereafter throughout the laying period (40 wk). Furthermore, egg size and shell thickness, as determined by egg weight and specific gravity measurements made at various intervals during egg lay, as well as hen body weight gain, were unaffected by treatment with MBP-cINA 521 . These data suggest that: 1) the additional eggs harvested as a result of vaccination with MBP-cINA 521 were of normal egg quality, and 2) the vaccine did not alter the body weight of spent hens. Studies on the vaccine's effect on fertility and hatchability of eggs, as well as livability of chicks hatched from eggs laid by vaccinated birds, are forthcoming.
Mortality rates, albeit generally higher than expected, were similar among the CON and two lowest-dose MBPcINA 521 treatment groups. Inclusive in these groups was the intermediate test dose of MBP-cINA 521 that was associated with the greatest enhancement of reproductive performance. The generally higher than expected mortality rates are not surprising when consideration is given to the fact that the trial was conducted in an open-sided, fan-ventilated house in southern Louisiana. Indeed, the first half of the trial (initial 20 wk of lay) occurred during the summer or hottest part of the year (April through September). Mortality rates are typically higher than industry standards in broiler breeder trials conducted during the summer months at Louisiana State University. Moreover, the current trial was conducted in 1998, a record year for high summer temperatures in Louisiana. Temperatures often exceeded 37.8 C for several consecutive days and heat prostration was an unavoidable consequence.
Postmortem veterinarian inspections revealed that nearly 70% of all deaths (trialwise, full 40 wk of lay) were caused by high temperature exposure, and, of all the birds determined to have died from this exposure, 100% did so within the first 20 wk of lay (i.e., during the hottest part of the year). Mortality was further exacerbated in hens given the highest immunogen dose beyond that observed in the CON and two lowest immunogen groups. At first glance, this finding would appear to be related to the vaccine's dosage. However, this conclusion should be guarded as in other broiler breeder trials (Satterlee, unpublished data) mortality was unaffected by the administration of MBP-cINA 521 at dosages equal to or above the highest dose used in the present study. An explanation for the higher mortality that was observed in the highest dose treatment group is not readily apparent.
High ambient temperature also likely contributed to the delay in puberty and lowered HDEP rates and egg SG measures observed in CON hens (as compared to industry values for these variables). In addition, puberty might have been adversely affected in our controls because the commercially grown pullets that we purchased at 20 wk of age were approximately 10% below the body weight recommendation for Classic Females specified by Arbor Acres for birds of this age. It should also be noted that primary breeders typically publish egg production values that represent the average production response observed from the top 20% of flocks. The purposeful use of such inflated numbers gives producers a target goal (i.e., a best-case scenario that one might reasonably expect under optimal management conditions). Our CON HDEP values were also derived from trap-nested hens (potentially a more stressful management paradigm than the communal nest systems used commercially). Finally, because we were unable to assign eggs that were laid on the floor or on the slats to individual hens (i.e., treatments), our egg production values would also be compromised by such egg losses. Nevertheless, despite all these limitations, unlike the CON hen responses, immunized hens, particularly those that received the intermediate dose of MBP-cINA 521 , reached puberty milestones as well as peak and overall HDEP rates that were more consistent with industry values.
This finding at least speaks to the efficacy and importance of the approach of using inhibin immunoneutralization to enhance egg lay in broiler breeder hens that are unavoidably managed under less than optimal conditions (e.g., on farms that do not have evaporative cooling systems, during times of uncontrollable, extreme weather conditions, etc.).
At the end of the trial, antibodies directed against a recombinant α-inhibin fragment (Histag-cINA 521 ) were found in plasma collected from birds given each dose of the test substance (MBP-cINA 521 ) but not in plasma harvested from CON-treated birds. These findings support our previous observations in quail that the same antigen was capable of producing positive antibody titer responses by ELISA (Moreau et al., 1998) . The demonstrations of humoral immune responses to MBP-cINA 521 in quail and chickens are in keeping with the proposed mechanisms of how active immunization against inhibin amplifies female production performance. We suggest that antibodies produced post-MBP-cINA 521 challenge are directed against the test substance and native inhibins. Diminution of the negative influences of endogenous inhibins on FSH activity on the ovary likely resulted in the maturation of more ova in the follicular hierarchy, which would explain our observations of an early onset of puberty and increased HDEP rates in quail (Moreau et al., 1998) and chicken hens (herein) vaccinated with MBPcINA 521 .
In further support of the above proposed mechanism are our recent findings ) that broiler breeder hens given an effective dose of MBP-cINA 521 exhibited, after 30 wk of lay, a greater number of midsized, ovarian follicles (yellow follicles, 4 to 7 mm in diameter) and larger and heavier preovulatory follicles (8 to 35 mm) than did controls. In these studies, the ovarian pattern observed in immunized hens (an enhanced and perfectly ordered follicular hierarchy) was consistent with their superior rate of lay. Interestingly, in egg-type chickens, Lovell et al. (2001) found that although inhibin immunization did not advance the onset of lay [unlike our findings with Coturnix; Moreau et al. (1998) , and herein], challenge with an inhibin-based antigen was associated with a selective twofold increase in the number of 8-to-9.99-mm-diameter follicles, a size class that corresponds to ova that have just joined the preovulatory heirarchy. In their study, no other follicle size-class was altered by inhibin immunization, yet an elevated number of postovulatory follicles was evident, and they observed a higher incidence of double egg lay within 24 h in treated birds. These workers reasoned that many of the ova from immunized hens must have ovulated into the abdominal cavity or were reabsorbed in the oviduct because the extra eggs reflected by the elevation in postovulatory follicles were not represented by ovipositions. The differences in our studies of follicle size class and those of Lovell et al. (2001) might reflect the different types of fowl studied, differences in lighting regimes and potencies of test substances, and other yet unidentified factors. Endocrine-driven follicular hierarchy events might be quite different in egg-type stocks that are genetically predisposed to maximum egg lay.
The finding of greater mean inhibin antibody titers in the low and intermediate antigen dose groups than those found in the highest dose might reflect immunological tolerance. This finding would also be consistent with the observation of a lesser elevation above the control response in cumulative HDEP in hens treated with the highest dose of MBP-cINA 521 than the other two treatment doses.
In conclusion, our findings of a positive impact of active immunization against inhibin on egg lay in quail (Moreau et al., 1998) and in chickens (present studies) supports the much broader-based and more voluminous literature that has documented increased ovulation rates after inhibin immunoneutralization in a variety of mammalian species (e.g., heifers, ewes, gilts, and rats; see Introduction). It should also be noted that since our initial report in quail, our laboratory has also shown, in a preliminary report, that the MBP-cINA 521 antigen is efficacious in increasing egg lay in yet a third avian species, the domestic turkey (Cadd et al., 1999 ). An abstract by other workers (Ahn et al., 1999) has also since documented that a significantly different inhibin-based antigen (recombinant turkey α-inhibin conjugated to keyhole limpet hemocyanin), when used in an inhibin immunoneutalization scheme, is capable in turkeys of increasing the number of nongraded ovarian yellow follicles. In the same study, injection with the turkey inhibin antigen also caused increases in the levels of mRNA FSH in pituitary extracts (El Halawani, personal communication) .
The growing avian literature that supports the efficacy of inhibin immunoneutralization to enhance egg lay in domestic fowl may have strategic relevance to the poultry industry. Historically, the ever-increasing public demand for low-cost poultry meats and products has largely been met by significant improvements in genetics, nutrition, and management. However, it is becoming increasingly difficult to make major advancements in these areas with regard to increasing the efficiency of poultry production. A safe and cost-effective vaccine that would substantially increase the number of fertile eggs harvested from breeder hens during a normal breeding cycle would permit production of projected egg needs with fewer hens. This method would represent significant savings in the cost of producing a chick from broiler breeder multiplier flocks and, to a lesser extent, certain primary breeder flocks. Breeder hen studies designed to assess the effects of active immunization against inhibin on fertility, hatchability, and livability constitute logical next steps.
